-
1
-
-
0034623019
-
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
-
Plana M, Garcia F, Gallart T, et al. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS 2000, 14:1921-33.
-
(2000)
AIDS
, vol.14
, pp. 1921-1933
-
-
Plana, M.1
Garcia, F.2
Gallart, T.3
-
2
-
-
0030052964
-
Alterations of the immune response of HIV-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
-
Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations of the immune response of HIV-infected subjects treated with an HIV-specific protease inhibitor, Ritonavir. J Infect Dis 1996, 173:321-329.
-
(1996)
J Infect Dis
, vol.173
, pp. 321-329
-
-
Kelleher, A.D.1
Carr, A.2
Zaunders, J.3
Cooper, D.A.4
-
3
-
-
0030868897
-
Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
-
Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
-
(1997)
Science
, vol.277
, pp. 112-116
-
-
Autran, B.1
Carcelain, G.2
Li, T.S.3
-
4
-
-
17344369291
-
Improvement in cell-mediated immune function, during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir
-
Angel JB, Kumar A, Parato K, et al. Improvement in cell-mediated immune function, during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J Infect Dis 1998, 177:808-904.
-
(1998)
J Infect Dis
, vol.177
, pp. 808-904
-
-
Angel, J.B.1
Kumar, A.2
Parato, K.3
-
5
-
-
0032490305
-
Long-lasting recovery in CD4 T cell function and viral load reduction after HAART in advanced HIV-1 disease
-
Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T cell function and viral load reduction after HAART in advanced HIV-1 disease. Lancet 1998, 351:1682-1686.
-
(1998)
Lancet
, vol.351
, pp. 1682-1686
-
-
Li, T.S.1
Tubiana, R.2
Katlama, C.3
Calvez, V.4
Ait Mohand, H.5
Autran, B.6
-
6
-
-
17344365057
-
Immunologic responses associated with 12 weeks of combination therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS clinical trial group protocol 315
-
Lederman MM, Connick E, Landay A, et al. Immunologic responses associated with 12 weeks of combination therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS clinical trial group protocol 315. J Infect Dis 1998, 178:70-79.
-
(1998)
J Infect Dis
, vol.178
, pp. 70-79
-
-
Lederman, M.M.1
Connick, E.2
Landay, A.3
-
7
-
-
0034119250
-
Long-term immunological response in HIV-1 infected subjects receiving potent antiretroviral therapy
-
Kaufmann GR, Bloch M, Zaunders JJ, et al. Long-term immunological response in HIV-1 infected subjects receiving potent antiretroviral therapy. AIDS 2000, 14:959-969.
-
(2000)
AIDS
, vol.14
, pp. 959-969
-
-
Kaufmann, G.R.1
Bloch, M.2
Zaunders, J.J.3
-
8
-
-
0033051593
-
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy
-
Pontesilli O, Kerkhof-Garde S, Notermans DW, et al. Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy. J Infect Dis 1999, 180:76-86.
-
(1999)
J Infect Dis
, vol.180
, pp. 76-86
-
-
Pontesilli, O.1
Kerkhof-Garde, S.2
Notermans, D.W.3
-
9
-
-
0002349021
-
Longitudinal studies of HIV gag-specific cytotoxic T lymphocyte responses over time in several patients
-
Racz P, Letvin NL, Gluckman JC (editors). Basel: Karger
-
Gotch FM, Rowland-Jones S, Nixon DF. Longitudinal studies of HIV gag-specific cytotoxic T lymphocyte responses over time in several patients. In: Cytotoxic T cells in HIV infection. Racz P, Letvin NL, Gluckman JC (editors). Basel: Karger; 1992. pp. 60-72.
-
(1992)
Cytotoxic T cells in HIV infection
, pp. 60-72
-
-
Gotch, F.M.1
Rowland-Jones, S.2
Nixon, D.F.3
-
10
-
-
0028236515
-
Long-term asymptomatic HIV-1 infection with normal and low CD4 counts
-
Keet IPM, Krol A, Klein MR, et al. Long-term asymptomatic HIV-1 infection with normal and low CD4 counts. J Infect Dis 1994, 169:1236-1241.
-
(1994)
J Infect Dis
, vol.169
, pp. 1236-1241
-
-
Keet, I.P.M.1
Krol, A.2
Klein, M.R.3
-
11
-
-
0028978720
-
Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS
-
Riviere Y, McChesney MB, Porrot F, et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retrovir 1995, 11:903-907.
-
(1995)
AIDS Res Hum Retrovir
, vol.11
, pp. 903-907
-
-
Riviere, Y.1
McChesney, M.B.2
Porrot, F.3
-
12
-
-
8944257611
-
Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection
-
Clerici M, Balotta C, Trabattoni D, et al. Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996; 88:574-579.
-
(1996)
Blood
, vol.88
, pp. 574-579
-
-
Clerici, M.1
Balotta, C.2
Trabattoni, D.3
-
13
-
-
0030665257
-
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
-
Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997, 278:147-150.
-
(1997)
Science
, vol.278
, pp. 147-150
-
-
Rosenberg, E.S.1
Billingsley, J.M.2
Caliendo, A.M.3
-
14
-
-
0033999127
-
Different immunologic profiles characterize HIV infection in HAART-treated and antiretroviral-naive patients with undetectable viremia
-
Clerici M, Seminari E, Suter F, et al. Different immunologic profiles characterize HIV infection in HAART-treated and antiretroviral-naive patients with undetectable viremia. AIDS 2000, 4:109-116.
-
(2000)
AIDS
, vol.4
, pp. 109-116
-
-
Clerici, M.1
Seminari, E.2
Suter, F.3
-
15
-
-
0030768593
-
Overshoot of HIV-1 viremia after discontinuation of antiretroviral treatment
-
de Jong M, de Boer RN, de Wolf F, et al. Overshoot of HIV-1 viremia after discontinuation of antiretroviral treatment. AIDS 1997, 1:F79-F84.
-
(1997)
AIDS
, vol.1
-
-
De Jong, M.1
De Boer, R.N.2
De Wolf, F.3
-
16
-
-
0032581589
-
Rebound of HIV plasma viremia following prolonged suppression with combination therapy
-
Montaner JSG, Harris M, Mo T, Harrigan PR. Rebound of HIV plasma viremia following prolonged suppression with combination therapy. AIDS 1998, 12:1398-1399.
-
(1998)
AIDS
, vol.12
, pp. 1398-1399
-
-
Montaner, J.S.G.1
Harris, M.2
Mo, T.3
Harrigan, P.R.4
-
17
-
-
0033004630
-
Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy
-
Harrigan PR, Whaley M, Montaner JSG. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS 1999, 13:F59-F62.
-
(1999)
AIDS
, vol.13
-
-
Harrigan, P.R.1
Whaley, M.2
Montaner, J.S.G.3
-
18
-
-
0032819454
-
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy
-
Garcia F, Plana M, Vidal C, et al. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. AIDS 1999, 13:F79-F86.
-
(1999)
AIDS
, vol.13
-
-
Garcia, F.1
Plana, M.2
Vidal, C.3
-
19
-
-
0032578854
-
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously naive HIV-1-infected patients
-
Pialoux G, Raffi F, Brun-Vezinet F, et al. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously naive HIV-1-infected patients. N Engl J Med 1998, 339:1269-1276.
-
(1998)
N Engl J Med
, vol.339
, pp. 1269-1276
-
-
Pialoux, G.1
Raffi, F.2
Brun-Vezinet, F.3
-
20
-
-
0032578860
-
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy
-
Havlir DV, Marschner IC, Hirsch MS, et al. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. N Engl J Med 1998, 339:1261-1268.
-
(1998)
N Engl J Med
, vol.339
, pp. 1261-1268
-
-
Havlir, D.V.1
Marschner, I.C.2
Hirsch, M.S.3
-
21
-
-
19244367532
-
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
-
Reijers MH, Weverling GJ, Jurriaans S, et al. Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study. Lancet 1998, 352:185-190.
-
(1998)
Lancet
, vol.352
, pp. 185-190
-
-
Reijers, M.H.1
Weverling, G.J.2
Jurriaans, S.3
-
22
-
-
0032547526
-
Caution: Should we be treating HIV infection early?
-
Levy JA. Caution: should we be treating HIV infection early? Lancet 1998, 352:982-983.
-
(1998)
Lancet
, vol.352
, pp. 982-983
-
-
Levy, J.A.1
-
23
-
-
0032578839
-
Therapeutic strategies for HIV infection. Time to think hard
-
Cooper DA. Therapeutic strategies for HIV infection. Time to think hard. N Engl J Med 1998, 339:1297-1299.
-
(1998)
N Engl J Med
, vol.339
, pp. 1297-1299
-
-
Cooper, D.A.1
-
24
-
-
0024385934
-
IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals
-
Clerici M, Stocks NI, Zajac RA, et al. IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals. Nature 1989, 339:383-386.
-
(1989)
Nature
, vol.339
, pp. 383-386
-
-
Clerici, M.1
Stocks, N.I.2
Zajac, R.A.3
-
25
-
-
0035865865
-
Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression
-
Angel JB, Parato KG, A Kumar, et al. Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression. J Infect Dis 2001, 185:546-554.
-
(2001)
J Infect Dis
, vol.185
, pp. 546-554
-
-
Angel, J.B.1
Parato, K.G.2
Kumar, A.3
-
26
-
-
0035865868
-
Proliferative responses to human immunodeficiency virus type 1 antigens in HIV-1-infected patients with immune reconstitution
-
Blankson JN, Gallant JE, Siliciano RF. Proliferative responses to human immunodeficiency virus type 1 antigens in HIV-1-infected patients with immune reconstitution. J Infect Dis 2001, 183:657-661.
-
(2001)
J Infect Dis
, vol.183
, pp. 657-661
-
-
Blankson, J.N.1
Gallant, J.E.2
Siliciano, R.F.3
-
27
-
-
0032499143
-
Improvement in CD4+ T cell counts despite persistently detectable HIV viral load
-
Levitz SM. Improvement in CD4+ T cell counts despite persistently detectable HIV viral load. N Engl J Med 1998, 338:1074-1075.
-
(1998)
N Engl J Med
, vol.338
, pp. 1074-1075
-
-
Levitz, S.M.1
-
28
-
-
0032492398
-
CD4 cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
-
Kauffman D. CD4 cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Lancet 1998, 351:723-724.
-
(1998)
Lancet
, vol.351
, pp. 723-724
-
-
Kauffman, D.1
-
29
-
-
0034943570
-
Prevalence and predictive of intermittent viremia with combination HIV therapy
-
Havlir DV, Bassett R, Leviatan R, et al. Prevalence and predictive of intermittent viremia with combination HIV therapy. JAMA 2001, 286:171-179.
-
(2001)
JAMA
, vol.286
, pp. 171-179
-
-
Havlir, D.V.1
Bassett, R.2
Leviatan, R.3
-
30
-
-
0032789091
-
Levels of HIV-1-specific cytotoxic T lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral theraphy
-
Kalams SA, Goulder PJ, Shea AK, et al. Levels of HIV-1-specific cytotoxic T lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral theraphy. J Virol 1999, 73:6721-6728.
-
(1999)
J Virol
, vol.73
, pp. 6721-6728
-
-
Kalams, S.A.1
Goulder, P.J.2
Shea, A.K.3
-
31
-
-
0343183221
-
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency
-
Rinaldo CR Jr, Huang XL, Fan Z, et al. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency. J Virol 2000, 74:4127-4138.
-
(2000)
J Virol
, vol.74
, pp. 4127-4138
-
-
Rinaldo C.R., Jr.1
Huang, X.L.2
Fan, Z.3
-
32
-
-
0034623019
-
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
-
Plana M, Garcia F, Gallart T, et al. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS 2000, 14:1921-1933.
-
(2000)
AIDS
, vol.14
, pp. 1921-1933
-
-
Plana, M.1
Garcia, F.2
Gallart, T.3
-
33
-
-
0035282636
-
Alterations in T cell phenotype and HIV-1 specific cytotoxicity after potent antiretroviral therapy
-
Seth A, Markee J, Hoering A, et al. Alterations in T cell phenotype and HIV-1 specific cytotoxicity after potent antiretroviral therapy. J Infect Dis 2001, 183:722-729.
-
(2001)
J Infect Dis
, vol.183
, pp. 722-729
-
-
Seth, A.1
Markee, J.2
Hoering, A.3
-
34
-
-
0033524838
-
Control of viremia in simian immunodeficiency virus infection by CD8+ T lymphocytes
-
Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ T lymphocytes. Science 1999, 283:857-860.
-
(1999)
Science
, vol.283
, pp. 857-860
-
-
Schmitz, J.E.1
Kuroda, M.J.2
Santra, S.3
-
35
-
-
0032973455
-
In vivo migration and function of transferred HIV-1-speciflc cytotoxic T cells
-
Brodie SJ, Lewinsohn DA, Patterson BK, et al. In vivo migration and function of transferred HIV-1-speciflc cytotoxic T cells. Nat Med 1999, 5:34-41.
-
(1999)
Nat Med
, vol.5
, pp. 34-41
-
-
Brodie, S.J.1
Lewinsohn, D.A.2
Patterson, B.K.3
-
36
-
-
0022967777
-
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication
-
Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ Lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986, 234:1563-1566.
-
(1986)
Science
, vol.234
, pp. 1563-1566
-
-
Walker, C.M.1
Moody, D.J.2
Stites, D.P.3
Levy, J.A.4
-
37
-
-
0030009546
-
Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells
-
Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 1996, 17:217-224.
-
(1996)
Immunol Today
, vol.17
, pp. 217-224
-
-
Levy, J.A.1
Mackewicz, C.E.2
Barker, E.3
-
38
-
-
0029417004
-
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
-
Cocchi F, De Vico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.
-
(1995)
Science
, vol.270
, pp. 1811-1815
-
-
Cocchi, F.1
De Vico, A.L.2
Garzino-Demo, A.3
Arya, S.K.4
Gallo, R.C.5
Lusso, P.6
-
39
-
-
0031757825
-
Role of interleukin-7 in T-cell development from hematopoietic stem cells
-
Akashi K, Kondo M, Weissman IL. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol Rev 1998, 165:13-28.
-
(1998)
Immunol Rev
, vol.165
, pp. 13-28
-
-
Akashi, K.1
Kondo, M.2
Weissman, I.L.3
-
40
-
-
0031656033
-
IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells
-
Hassan J, Reen DJ. IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells. Eur J Immunol 1998, 28:3057-3065.
-
(1998)
Eur J Immunol
, vol.28
, pp. 3057-3065
-
-
Hassan, J.1
Reen, D.J.2
-
41
-
-
0003267921
-
A potential role for IL-7 in homeostasis in HIV infected patients
-
San Francisco, CA (USA), 30 January-2 February [Abstract LB1]
-
Fry TJ, Connick E, Landay A, et al. A potential role for IL-7 in homeostasis in HIV infected patients. In: 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA (USA), 30 January-2 February 2000 [Abstract LB1].
-
(2000)
7th Conference on Retroviruses and Opportunistic Infections
-
-
Fry, T.J.1
Connick, E.2
Landay, A.3
-
42
-
-
0034548861
-
T lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV
-
Clerici M, Saresella M, Colombo F, et al. T Lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000, 96:3866-3871.
-
(2000)
Blood
, vol.96
, pp. 3866-3871
-
-
Clerici, M.1
Saresella, M.2
Colombo, F.3
-
43
-
-
0035138982
-
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: Implications for T-cell homeostasis
-
Napolitano LA, Grant RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001, 7:73-79.
-
(2001)
Nat Med
, vol.7
, pp. 73-79
-
-
Napolitano, L.A.1
Grant, R.M.2
Deeks, S.G.3
|